Analysts at Redburn Atlantic initiated coverage on shares of DexCom (NASDAQ:DXCM – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The brokerage set a “neutral” rating and a $130.00 price target on the medical device company’s stock. Redburn Atlantic’s price objective would suggest a potential upside of 9.46% from the […]